Epify BV

Facilitating cancer diagnosis and personalized treatments through epigenetic biomarkers.

[Epify BV @BvEpify]

Epify has been awarded an MIT grant from the Dutch government! 🥳 This will help us demonstrate the technical and economic feasibility of our first epigenetic biomarker test kit for clinical use. Stay tuned!
https://t.co/9PKZC6Jucg
#cancer #diagnostics

[Epify BV @BvEpify]

Colorectal cancer survival rates and health economics demonstrate a clear need for #earlydetection

At Epify we believe we can lead change and beat cancer with #epigeneticbiomarkers

Source: DiCE Roadmap for the prevention and treatment of colorectal cancer in Europe (2020).

[Epify BV @BvEpify]

The 5-year survival rates are obvious, early detection saves lives. Money can also be saved when investing in #cancerscreening and #earlydetection

Source on cancer expenditures in Europe: https://t.co/w291dw9CvV

[Epify BV @BvEpify]

#epigenetics, epi (=on top) of genetics. There is more than genetics and proteomics, the next generation of biomarkers will be based on epigenetic mechanisms.

[Epify BV @BvEpify]

The liquid biopsy market continues to grow. With a simple blood draw, various cancers can be diagnosed early.
#earlydetection #epigenetics

Sources: BCC Publishing 2021: Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets and https://t.co/9DL75nBmx1

[Epify BV @BvEpify]

Epigenetic biomarkers are the most promising response to the complexity of diseases such as cancer. The time to commercialize academically discovered epigenetic biomarkers to clinical practice is now.

[Epify BV @BvEpify]

We are pleased to officially announce our patent filing in the colorectal cancer (CRC) program, claiming multiple epigenetic biomarkers for a broad range of applications including tissue, blood and stool.

#patent #epigenetics #biomarkers

see: https://t.co/5pbw7Fivz7

[Epify BV @BvEpify]

Epify’s mission is to discover cancer before patients suffer from symptoms! With early detection and intervention, more people survive cancer with minimally invasive procedures. #earlydetection

Source: Chamoun et al. (2021)

[Epify BV @BvEpify]

Thank you for the great partnering opportunities #meet2win #BiotechgateDigtalPartnering

Looking forward to more partnering, also in the next editions.

#biomarkers #epigenetics #earlydetection

[Epify BV @BvEpify]

Epify is represented at #BiotechgateDigtalPartnering

Reach out to us for a virtual meet-up to hear more about our developments in #epigenetics and #biomarkers in the field of #oncology

[Epify BV @BvEpify]

Epify thrives on virtual meetings. We rarely miss out on our weekly team meetings.

How?
-It is our time with the team, together.
-We have our routine and avoid calendar conflicts.
-We never take longer than 1 hour.

Thank you team Epify for being so committed!

[Epify BV @BvEpify]

Did you know that April is #NationalCancerControlMonth ?

Cancer risk can be reduced. Avoiding tobacco, protecting skin, limiting alcohol intake and keeping a healthy diet and weight can help lowering risk.

[Epify BV @BvEpify]

The journey to good health is not always easy, but it is rewarding. Start or keep up with healthy lifestyle choice but also accept invitations for #cancerscreenings.

#worldhealthday

[Epify BV @BvEpify]

March is #ColorectalCancerAwarenessMonth.

Learn more about the costs related to CRC: https://t.co/VRagLrFPF5

[Epify BV @BvEpify]

March is #ColorectalCancerAwarenessMonth. To learn more about CRC survival by stage https://t.co/3OD7N7vKo5

[Epify BV @BvEpify]

March is #ColorectalCancerAwarenessMonth.

To learn more about CRC indicine and mortality read:
https://t.co/zpSgUVEcIx

[Epify BV @BvEpify]

At Epify we celebrate each other during #internationalwomensday2021
We embrace the diversity that we enjoy because of the flexibility and adaptability that we cherish.

[Epify BV @BvEpify]

Early #cancer #diagnosis leads to better patient outcomes. The USPSTF has now published a draft recommendation to start #colorectalcancer screening at age 45 instead of 50: https://t.co/ktTxrMWir7

[Epify BV @BvEpify]

New performance requirements for blood-based biomarker tests for CRC screening published by @CMSGov: https://t.co/9CCsqh1HqJ
#colorectalcancer #diagnostics

[BioLizard @BioLizard_nv]

At the beginning of this month, they announced that the Nobel Prize in Chemistry would be awarded to two female scientists for their work on #genomeediting. This is the first time the award has gone to two women. Find out more 👉 https://t.co/LoOQgdSJWJ
#nobelprize2020

[Epify BV @BvEpify]

We’re on cloud nine! Through our partner @BiotechNovalis we got the opportunity to join the @AWSstartups program. This will help us scale our #bioinformatics analyses and marker discovery pipelines, bringing us closer to better #cancer #diagnostics and personalized #oncology.